Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 8

Feasibility, Reliability, and Validity of the Turkish Version of the Esophageal-Atresia-Quality-of-Life Questionnaires to Assess Condition-Specific Quality of Life in Children and Adolescents Born with Esophageal Atresia

Pages
640–650
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The Turkish version of the EA-QOL questionnaires is feasible, valid, and reliable to assess condition-specific HRQOL in EA children.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:(EA-QOL) questionnaires, which were originally developed in Sweden and Germany.
📊
Key Findings & Data:Methods: After translation from Swedish to Turkish and cognitive debriefings, 51 families of children aged 2-7 years (parent-reported, 17 items) and 54 families of children 8-17 years (child-reported and parent-reported, 24 items) responded to the EA-QOL questionnaires and a validated generic HRQOL instrument (PedsQL4.0).
💡
Conclusion & Impact:Conclusion: The Turkish version of the EA-QOL questionnaires is feasible, valid, and reliable to assess condition-specific HRQOL in EA children.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

(EA-QOL) questionnaires, which were originally developed in Sweden and Germany. Methods: After translation from Swedish to Turkish and cognitive debriefings, 51 families of children aged 2-7 years (parent-reported, 17 items) and 54 families of children 8-17 years (child-reported and parent-reported, 24 items) responded to the EA-QOL questionnaires and a validated generic HRQOL instrument (PedsQL4.0). The medical records of the patients and the questionnaires were used to obtain clinical data. The Turkish version of the EA-QOL questionnaires were evaluated for feasibility (<5% missing item responses), reliability (internal consistency/retest reliability for 3 weeks), and validity (known groups/concurrent/convergent). The level of significance was P < .05. Results: The feasibility of the Turkish version of the EA-QOL questionnaires was good. The internal consistency of all scales was satisfactory, as were the levels of agreement of EA-QOL scores between the field study and the retest study. Known-group validity and concurrent validity were achieved, since the EA-QOL questionnaires showed that esophageal symptoms and feeding difficulties were negatively associated with EA-QOL total scores, both in the age-specific versions (child-reported and parent- reported), and with respect to respiratory symptoms in the version for EA children 2-7 years (parent-reported). A higher number of respiratory symptoms decreased the EA-QOL total scores in both age groups (parent-reported, P < .05). Correlations between the EA-QOL total scores and PedsQL-4.0 total scores supported convergent validity. Conclusion: The Turkish version of the EA-QOL questionnaires is feasible, valid, and reliable to assess condition-specific HRQOL in EA children.

🔖

Cite This Article

SOYER, T., ARSLAN, U. E., DURAKBAŞA, Ç. U., AYDONER, S., TÜRER, Ö. B., QUİTMANN, J. H., DİNGEMANN, J., DELLENMARK-BLOM, M. (2021). Feasibility, Reliability, and Validity of the Turkish Version of the Esophageal-Atresia-Quality-of-Life Questionnaires to Assess Condition-Specific Quality of Life in Children and Adolescents Born with Esophageal Atresia. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 8, 640–650. https://ajindex.com/articles/408855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ijsselstijn H, van Beelen N W, Wijnen R M. Esophageal atresia: longterm morbidities in adolescence and adulthood. Dis Esophagus. 2013;26:417-421. [CrossRef] 2. Kovesi T. Long-term respiratory complications of congenital esophageal atresia with or without tracheoesophageal fistula: an update. Dis Esophagus. 2013;26:413-416. [CrossRef] 3. Haverman L, Limperg PF, Young NL, Grootenhuis MA, Klaassen RJ. Paediatric health-related quality of life: what is it and why should we measure it? Arch Dis Child. 2017;102:393-400. [CrossRef] 4. Matza LS, Patrick DL, Riley AW, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health. 2013;16:461-479. [CrossRef] 5. United States Food and Drug Administration. Guidance for industry: patient-reported outcome measures. Use Med Prod Dev Support Labeling Claims USA. 2009:1-39. https://ww w.fda.gov/ downl oads/ drugs /guid ances /ucm1 93282.pdf. 6. Dellenmark-Blom M, Quitmann J, Dingemann C. Health-related quality of life in patients after repair of esophageal atresia: a review of current literature. Eur J Pediatr Surg. 2020;30:239-250. [CrossRef] 7. Dellenmark-Blom M, Chaplin JE, Gatzinsky V, Jönsson L, Abrahamson K. Health-related quality of life among children, young people and adults with esophageal atresia: a review of the literature and recommendations for future research. Qual Life Res. 2015;24:2433- 2445. [CrossRef] 8. Dingemann C, Meyer A, Kircher G, et al. Long-term health-related quality of life after complex and/or complicated esophageal atresia in adults and children registered in a German patient support group. J Pediatr Surg. 2014;49:631-638. [CrossRef] 9. Lepeytre C., De Lagausie P., Merrot T., et al. Medium-term outcome, follow-up, and quality of life in children treated for type III esophageal atresia. Arch Pediatr. 2013;20:1096-1104. [CrossRef] 10. Legrand C, Michaud L, Salleron J, et al. Long-term outcome of children with oesophageal atresia type III. Arch Dis Child. 2012;97:808- 811. [CrossRef] 11. Flieder S, Dellenmark-Blom M, Witt S, et al. Generic health related quality of life after repair of esophageal atresia and its determinants within a German-Swedish Cohort. Eur J Pediatr Surg. 2019;29:75-84. [CrossRef] 12. Amin R, Knezevich M, Lingongo M, et al. Long-term quality of life in neonatal surgical disease. Ann Surg. 2018;268:497-505. [C